237 related articles for article (PubMed ID: 21071689)
21. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
[TBL] [Abstract][Full Text] [Related]
22. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
Huang X; Swanson R; Kroh HK; Bock PE
J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
[TBL] [Abstract][Full Text] [Related]
23. Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.
Ayombil F; Abdalla S; Tracy PB; Bouchard BA
J Thromb Haemost; 2013 Aug; 11(8):1532-9. PubMed ID: 23710903
[TBL] [Abstract][Full Text] [Related]
24. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
25. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity.
Dörmann D; Clemetson KJ; Kehrel BE
Blood; 2000 Oct; 96(7):2469-78. PubMed ID: 11001899
[TBL] [Abstract][Full Text] [Related]
26. Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitro.
Bunce MW; Toso R; Camire RM
Blood; 2011 Jan; 117(1):290-8. PubMed ID: 20864578
[TBL] [Abstract][Full Text] [Related]
27. Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex.
Yegneswaran S; Banerjee Y; Fernández JA; Deguchi H; Griffin JH
PLoS One; 2015; 10(8):e0135025. PubMed ID: 26263376
[TBL] [Abstract][Full Text] [Related]
28. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
[TBL] [Abstract][Full Text] [Related]
29. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
30. A central role of GPIb-IX in the procoagulant function of platelets that is independent of the 45-kDa GPIbalpha N-terminal extracellular domain.
Ravanat C; Strassel C; Hechler B; Schuhler S; Chicanne G; Payrastre B; Gachet C; Lanza F
Blood; 2010 Aug; 116(7):1157-64. PubMed ID: 20457869
[TBL] [Abstract][Full Text] [Related]
31. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.
Gould WR; Silveira JR; Tracy PB
J Biol Chem; 2004 Jan; 279(4):2383-93. PubMed ID: 14594814
[TBL] [Abstract][Full Text] [Related]
32. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations.
Tracy PB; Eide LL; Mann KG
J Biol Chem; 1985 Feb; 260(4):2119-24. PubMed ID: 3972783
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa.
Mounier CM; Hackeng TM; Schaeffer F; Faure G; Bon C; Griffin JH
J Biol Chem; 1998 Sep; 273(37):23764-72. PubMed ID: 9726985
[TBL] [Abstract][Full Text] [Related]
34. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex.
Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
J Thromb Haemost; 2005 Nov; 3(11):2545-53. PubMed ID: 16241952
[TBL] [Abstract][Full Text] [Related]
35. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH
Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573
[TBL] [Abstract][Full Text] [Related]
36. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
Kempton CL; Hoffman M; Roberts HR; Monroe DM
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
[TBL] [Abstract][Full Text] [Related]
37. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.
Majumder R; Koklic T; Rezaie AR; Lentz BR
Biochemistry; 2013 Jan; 52(1):143-51. PubMed ID: 23214401
[TBL] [Abstract][Full Text] [Related]
39. Proposed structural models of the prothrombinase (FXa-FVa) complex.
Autin L; Steen M; Dahlbäck B; Villoutreix BO
Proteins; 2006 May; 63(3):440-50. PubMed ID: 16437549
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived microvesicles and activated platelets express factor Xa activity.
Holme PA; Brosstad F; Solum NO
Blood Coagul Fibrinolysis; 1995 Jun; 6(4):302-10. PubMed ID: 7548677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
